| Analysis | Samples | Factors | Units |
|---|---|---|---|
| NMR data | 4_1 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_11 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_12 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_15 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_20 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_21 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_22 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_24 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_26 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_28 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_29 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_34 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_35 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_40 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_42 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_46 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_49 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_51 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_54 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_58 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_7 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_8 | Time(weeks):4 | Treatment:Control | mM |
| NMR data | 4_10 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_14 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_17 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_2 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_23 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_25 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_27 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_30 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_31 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_33 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_36 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_37 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_38 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_39 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_43 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_44 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_45 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_47 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_48 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_5 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_50 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_52 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_53 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 4_57 | Time(weeks):4 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_1 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_11 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_12 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_15 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_20 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_21 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_22 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_26 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_28 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_29 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_3 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_34 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_40 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_41 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_42 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_46 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_58 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_6 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_7 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_8 | Time(weeks):52 | Treatment:Control | mM |
| NMR data | 52_10 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_14 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_16 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_17 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_19 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_2 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_23 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_25 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_27 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_30 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_36 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_37 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_38 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_39 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_43 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_44 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_45 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_47 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_48 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_5 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_52 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_57 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | 52_9 | Time(weeks):52 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_1 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_11 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_12 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_15 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_20 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_21 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_22 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_24 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_26 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_28 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_29 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_3 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_34 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_35 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_40 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_41 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_42 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_46 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_49 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_51 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_54 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_58 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_6 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_7 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_8 | Time(weeks):-8 | Treatment:Control | mM |
| NMR data | -8_10 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_14 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_17 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_19 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_2 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_23 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_25 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_27 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_30 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_31 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_33 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_36 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_37 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_38 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_39 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_43 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_44 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_45 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_47 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_48 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_5 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_50 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_52 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_53 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_57 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | -8_9 | Time(weeks):-8 | Treatment:GLP-1 analogue | mM |
| NMR data | 0_1 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_11 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_12 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_15 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_20 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_21 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_22 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_24 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_26 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_28 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_29 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_3 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_34 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_35 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_40 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_41 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_42 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_46 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_49 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_51 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_54 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_58 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_6 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_7 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_8 | Time(weeks):- | Treatment:Control | mM |
| NMR data | 0_10 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_14 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_16 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_17 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_19 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_2 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_23 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_25 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_27 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_30 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_31 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_33 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_36 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_37 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_38 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_39 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_43 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_44 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_45 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_47 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_48 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_5 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_50 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_52 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_53 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_57 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
| NMR data | 0_9 | Time(weeks):- | Treatment:GLP-1 analogue | mM |
Return to study ST000502 main page
Download data matrix(Weight loss and weight maintenance obtained with or without GLP-1 analogue treatment decrease branched chain amino acid levels. NMR data)
- Metabolomics Workbench
|